Clinical Predictors of Hearing Preservation in Ménière Disease

Authors

  • Fitria Waffi Nur Aini Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia
  • Mahatma Sotya Bawono Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia
  • Agus Surono Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia
  • Feri Trihandoko Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia

DOI:

https://doi.org/10.29103/jkkmm.v5i1.26438

Keywords:

Audiometri, prediktor klinis, pendengaran, penyakit Ménière, prognosis

Abstract

Hearing outcomes in Ménière disease are heterogeneous, ranging from prolonged fluctuation to irreversible decline and bilateral involvement. Because hearing level influences counselling and follow up planning, clinicians need practical predictors that are available from history taking and routine audiometry. This review summarises evidence published between 2016 and 2025 on clinical predictors associated with hearing preservation in Ménière disease. Across contemporary cohorts and meta analytic data, older age and longer disease duration are repeatedly associated with poorer hearing and a lower likelihood of maintaining serviceable thresholds. Baseline audiometry is the most actionable predictor, earlier stages and low frequency predominant loss show a greater probability of stable or improved thresholds with conservative management, while broader frequency involvement and early high frequency loss are linked to progression and increased risk of bilateral disease. Comorbid migraine and specific clinical phenotypes at onset have also been associated with bilateral involvement. Overall, age, disease duration, baseline stage, frequency pattern of loss, migraine history, and onset phenotypes form a framework for risk stratification and hearing follow up in Ménière disease.

References

1. Basura GJ, Adams ME, Monfared A, et al. Clinical Practice Guideline: Ménière's Disease. Otolaryngol Head Neck Surg. 2020 Apr;162(Suppl 2):S1 to S55.

2. Nevoux J, Barbara M, Dornhoffer J, Gibson W, Kitahara T, Darrouzet V. International consensus (ICON) on treatment of Ménière's disease. Eur Ann Otorhinolaryngol Head Neck Dis. 2018 Feb;135(1S):S29 to S32.

3. Mohseni-Dargah M, Falahati Z, Pastras C, Khajeh K, Mukherjee P, Razmjou A, Stefani S, Asadnia M. Meniere's disease: Pathogenesis, treatments, and emerging approaches for an idiopathic bioenvironmental disorder. Environ Res. 2023 Dec 1;238(Part 1):116972.

4. Zhang S, Guo Z, Tian E, et al. Meniere disease subtyping: the direction of diagnosis and treatment in the future. Expert Rev Neurother. 2022 Feb;22(2):115 to 127.

5. Pyykkö I, Zou J, Vetkas N. Changes in symptom pattern in Meniere's disease by duration: the need for comprehensive management. Front Neurol. 2024;15:1496384.

6. Frejo L, Soto-Varela A, Santos-Pérez S, et al. Clinical Subgroups in Bilateral Meniere Disease. Front Neurol. 2016 Oct 14;7:182.

7. Moleon MDC, Torres-Garcia L, Batuecas-Caletrio A, et al. A Predictive Model of Bilateral Sensorineural Hearing Loss in Meniere Disease Using Clinical Data. Ear Hear. 2022 May to Jun;43(3):1079 to 1085.

8. Lorente-Piera J, Blanco M, Santos-Garrido J, Manrique-Huarte R, Suárez-Vega V, Domínguez P, Fullaondo J, Arbizu L, Pérez-Fernández N. Functional Audiometric Dissociation in Ménière's Disease: Exploring the Mismatch Between Pure-Tone Thresholds and Speech Recognition. J Clin Med. 2025 Jul 4;14(13):4747.

9. Zhang Y, Wei C, Sun Z, Wu Y, Chen Z, Liu B. Hearing Benefits of Clinical Management for Meniere's Disease. J Clin Med. 2022 Jun 2;11(11):3131.

10. Miller BJ, Kallogjeri D, Shew MA, Piccirillo JF. Identifying Predictors of Treatment Response in Meniere's Disease: A Clinical Severity Staging System. Otolaryngol Head Neck Surg. 2024 Jan;170(1):212 to 220.

11. Hudson TJ, Kim BJ, Anderson J, et al. Long Term Risk of Progression From Unilateral to Bilateral Ménière's Disease: A Systematic Review and Meta Analysis. Otol Neurotol. 2025 Jun 1;46(5):485 to 493.

12. Pérez-Carbonell T, Orts-Alborch M, Pla-Gil I, et al. Bilateral Ménière's disease according to its form of debut: synchronous and metachronous disease. J Laryngol Otol. 2023 Jul;137(7):782 to 788.

13. Garaycochea O, Manrique-Huarte R, Calavia D, Girón L, Pérez-Fernández N. Speech Recognition During Follow-Up of Patients with Ménière's Disease: What Are We Missing? J Int Adv Otol. 2022 Jan;18(1):14 to 19.

14. Chen JY, Guo ZQ, Wang J, et al. Vestibular migraine or Meniere's disease: a diagnostic dilemma. J Neurol. 2023 May;270(5):1955 to 1968.

15. Zhang Y, Sun J, Chen Z, et al. Hearing loss rather than vestibular loss identifies patient subgroups with different outcomes in Meniere's disease. Int J Audiol. 2025 Jan 13:1 to 7.

Downloads

Published

2026-02-28